sec_filing· Regulatory
Will Celularity receive new FDA clinical clearance for a lead program?
Market overview
Derived from Celularity Inc (CELU) (CIK 0001752828) 10-Q filing analysis
Regulatory prediction market
- Implied probability (Yes)
- 30%
- Closes
- 2027-10-20
About this prediction
Resolution criteria
Celularity receives an IND approval or breakthrough designation from the FDA for a new program.
More Regulatory markets
- FIFA reinstates Balogun suspension within 30 days — 70% Yes
- UK issues travel advisory warning for southern Spain by 2026-07-25 — 80% Yes
- FIFA faces formal ethics complaint from UEFA by July 2026 — 75% Yes
- DCCC dues payment compliance increases by 2026 midterms — 75% Yes
- Forge Global secures Anthropic approval within 6 months — 75% Yes
- UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
- FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
- FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…